• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ACRES, PharmaTrain form alliance

ACRES, PharmaTrain form alliance

October 2, 2013
CenterWatch Staff

The Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge, Mass.-based global nonprofit, and PharmaTrain Federation, an international nonprofit organization for improving education and training of professionals in medicines development, have allied to promote the adoption of new and reliable global standards for high-quality postgraduate education and training for individuals pursuing careers in discovery, development, regulation and marketing of new medicines.

Dr. Greg Koski, president and CEO of ACRES, and Dr. Ingrid Klingmann, coordinator of PharmaTrain, said the goal of the partnership is to develop and implement a systems approach to addressing the many challenges currently facing global drug development and health-related research.

Proposed projects include the development and dissemination of curriculum standards for educational programs and the implementation of a global quality assessment and recognition process for educational programs and training courses, as part of the shared infrastructure necessary for the multi-stakeholder integration of education in medicines development.

 “PharmaTrain has defined 180 content topics in its comprehensive syllabus of medicines development and mapped them to 60 critical learning outcomes, which are aligned with the core competencies for scientists involved in medicines development,” said Koski. “This approach to standards-based education and training has been missing in preparing professionals in medicines development. Our alliance with PharmaTrain will facilitate the adoption and implementation of these standards worldwide with significant beneficial impact for the industry and for patients."

"PharmaTrain emerged as an education and training project within the European Innovative Medicines Initiative—it is now ready to undertake the next step for globalization," said Fritz Bühler, PharmaTrain’s founder, professor of pharmaceutical medicine and cardiology at the University of Basel and former head of global clinical R&D at Roche.

"To train a new generation of professionals in medicines development, a rigorous standardized but flexible curriculum is essential," said Klingmann, who also is chairman of the board of the European Forum for Good Clinical Practice (EFGCP). "Currently over 30 universities in Europe and North America have implemented the PharmaTrain curriculum—with ACRES, we intend to offer PharmaTrain to the world."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing